22.29
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
Is Surgery Partners Inc. a good long term investmentSuperior portfolio returns - Autocar Professional
Surgery Partners Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - jammulinksnews.com
What drives Surgery Partners Inc. stock priceExponentially increasing returns - jammulinksnews.com
Surgery Partners (SGRY): Buy, Sell, or Hold Post Q1 Earnings? - FinancialContent
What analysts say about Surgery Partners Inc. stockOutstanding stock performance - Autocar Professional
Long Term Trading Analysis for (SGRY) - news.stocktradersdaily.com
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Re - GuruFocus
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details - The Manila Times
Surgery Partners Sets Q2 Earnings Date: Key Financial Updates Coming August 5 - Stock Titan
Surgery Partners Stock Rises on Positive Analyst OutlookNews and Statistics - IndexBox
Why Surgery Partners (SGRY) Stock Is Trading Up Today - Yahoo Finance
Surgery Partners stock rises as CMS proposes favorable ASC rule changes - Investing.com Canada
Surgery Partners, Inc. (SGRY): A Bull Case Theory - Insider Monkey
1 Healthcare Stock to Keep an Eye On and 2 to Be Wary Of - Yahoo Finance
Surgery Partners stock rating reiterated by Cantor Fitzgerald at Overweight - Investing.com
(SGRY) Technical Data - news.stocktradersdaily.com
U.S. Ambulatory Surgery Center Market Growth in Future Scope - openPR.com
Surgery Partners to Acquire National Surgical Healthcare from Irving Place Capital - Bain Capital
Surgery Partners stock holds Buy rating at UBS on rejected Bain offer - Investing.com Canada
Surgery Partners stock hits 52-week low at 19.49 USD - Investing.com
Surgery Partners: The Plunge Doesn't Justify An Upgrade (NASDAQ:SGRY) - Seeking Alpha
Ascension Buying AmSurg in Response to Outpatient Trend - Healthcare Innovation
U.S. Ambulatory Surgery Center Market Generated - openPR.com
UBS reiterates buy rating on Surgery Partners stock amid takeover rejection - Investing.com
Surgery Partners’ SWOT analysis: stock outlook amid pricing pressures By Investing.com - Investing.com UK
Surgery Partners ends acquisition talks with Bain Capital By Investing.com - Investing.com India
Surgery Partners’ SWOT analysis: stock outlook amid pricing pressures - Investing.com
Surgery Partners rejects Bain Capital's takeover proposal - MSN
Surgery Partners Rejects $3.3B Bain Offer - USA Herald
Surgery Partners Ends Buyout Talks with Bain Capital, Shares Slide - GuruFocus
Surgery Partners Rejects $3.3B Bain Offer, Eyes Public Growth - Law360
Surgery Partners rejects Bain Capital's take-private offer - Reuters
Surgery Partners rejects Bain Capital's acquisition offer, opts to remain public - The Business Journals
RSI Alert: Surgery Partners (SGRY) Now Oversold - Nasdaq
Surgery Partners falls after it rejects Bain Capital's take-private offer - TradingView
Surgery Partners’ Stock Dips Amid Expert Analysis of Latest Financials - timothysykes.com
Surgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private Proposal By Stocktwits - Investing.com India
Bain Capital Private Equity, LP cancelled the acquisition of remaining 60.7% stake in Surgery Partners, Inc.. - MarketScreener
Surgery Partners rejects Bain Capital’s take-private offer - 1470 & 100.3 WMBD
Surgery Partners Rejects Bain Capital's Private Buyout Offer, Will Remain Independent - Benzinga
Surgery Partners rejects Bain Capital's takeover proposal (SGRY) - Seeking Alpha
Surgery Partners stock falls after concluding discussions with Bain Capital - Investing.com
Surgery Partners ends acquisition talks with Bain Capital - Investing.com
Surgery Partners Decides to Remain Independent - TipRanks
Surgery Partners (SGRY) Confirms 2025 Financial Projections | SG - GuruFocus
Surgery Partners, Bain Capital conclude discussions - TipRanks
SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions - The Manila Times
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):